Wolf Ido, Sadetzki Siegal, Catane Raphael, Karasik Avraham, Kaufman Bella
Institute of Oncology, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
Lancet Oncol. 2005 Feb;6(2):103-11. doi: 10.1016/S1470-2045(05)01736-5.
Type 2 diabetes is a serious health problem that affects more than 7% of adults in developed countries. Up to 16% of patients with breast cancer have diabetes, and two major risk factors for type 2 diabetes-old age and obesity-are also associated with breast cancer. Three mechanisms have been postulated to associate diabetes with breast cancer: activation of the insulin pathway, activation of the insulin-like-growth-factor pathway, and regulation of endogenous sex hormones. Comparative cohort studies and case-control studies suggest that type 2 diabetes may be associated with 10-20% excess relative risk of breast cancer. Gestational diabetes mellitus, but not type 1 diabetes, might also be associated with excess risk of breast cancer. Moreover, diabetes and its complications can adversely affect cancer therapy and the use of screening, which will thus affect the outcome of patients with breast cancer.
2型糖尿病是一个严重的健康问题,在发达国家影响着超过7%的成年人。高达16%的乳腺癌患者患有糖尿病,而2型糖尿病的两个主要危险因素——老年和肥胖——也与乳腺癌相关。有三种机制被假定为将糖尿病与乳腺癌联系起来:胰岛素途径的激活、胰岛素样生长因子途径的激活以及内源性性激素的调节。比较队列研究和病例对照研究表明,2型糖尿病可能与乳腺癌相对风险增加10% - 20%相关。妊娠糖尿病而非1型糖尿病,也可能与乳腺癌风险增加相关。此外,糖尿病及其并发症会对癌症治疗和筛查的使用产生不利影响,从而影响乳腺癌患者的治疗结果。